BAIN CAPITAL LIFE SCIENCES
Bain Capital Life Sciences specializes in buyouts, inflexion capital, growth capital, turnaround investments, and private equity. It invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of the Bain Capital Life Sciences team enables it to deliver targeted capital and value-added strategic support to companies around critical phases of growth and inflexions in value.
BAIN CAPITAL LIFE SCIENCES
Industry:
Business Development Finance Financial Services
Founded:
2016-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.baincapitallifesciences.com
Total Employee:
11+
Status:
Active
Contact:
617-516-2000
Technology used in webpage:
IPv6 Cloudflare Hosting Japanese Yen Cloudflare DNS Cloudflare Challenge Cloudflare Automatic Challenge
Similar Organizations
Alter Equity 3P
Alter Equity3P specializes in growth capital and buyout investments.
Elevate Capital
Elevate Capital is a seed and early-stage investment firm with a focus in the Pacific Northwest and investing in under-represented founders.
Garnet Captive Services
Garnet Captive Services provides alternative risk consulting and brokerage services, including captive insurance program services.
Icon Ventures
Icon Ventures is a specialty venture capital firm focused on leading Series B or C financings.
Origin Ventures
Origin Ventures is an early-stage venture capital firm investing in software and marketing businesses enabling the Digital Native economy.
Point Field Partners
Point Field Partners main investment areas are private equity, real estate, and venture capital.
Red Sea Ventures
Red Sea Ventures is a venture capital firm that specializes in early stage investments based in New York.
Redfield Proctor
Marketplace
The Cynosure Group
The Cynosure Group sources, evaluates and manages direct private equity investments in profitable, small to mid-sized companies
Twin Bridge Capital Partners
Leader in North American Small & Middle Market Private Equity Investing
Current Employees Featured
Coleman Mark Founder @ Bain Capital Life Sciences
Founder
Adam Koppel Managing Director @ Bain Capital Life Sciences
Managing Director
Mitt Romney Founder @ Bain Capital Life Sciences
Founder
Evan Greif Vice President @ Bain Capital Life Sciences
Vice President
2020-08-01
Benjamin Lund Partner @ Bain Capital Life Sciences
Partner
2018-01-01
Andrew Hack Managing Director @ Bain Capital Life Sciences
Managing Director
2019-03-01
Eric Kriss Founder @ Bain Capital Life Sciences
Founder
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-25 | Imperative Care | Bain Capital Life Sciences investment in Series E - Imperative Care | 150 M USD |
| 2024-07-16 | Cardurion Pharmaceuticals | Bain Capital Life Sciences investment in Series B - Cardurion Pharmaceuticals | 260 M USD |
| 2024-06-28 | Savara Pharmaceuticals | Bain Capital Life Sciences investment in Post-IPO Equity - Savara Pharmaceuticals | 100 M USD |
| 2024-05-13 | CereVasc | Bain Capital Life Sciences investment in Series B - CereVasc | 70 M USD |
| 2024-04-11 | Century Therapeutics | Bain Capital Life Sciences investment in Post-IPO Equity - Century Therapeutics | 60 M USD |
| 2024-03-28 | Xilio Therapeutics | Bain Capital Life Sciences investment in Post-IPO Equity - Xilio Therapeutics | 11.3 M USD |
| 2024-02-15 | Freenome | Bain Capital Life Sciences investment in Venture Round - Freenome | 254 M USD |
| 2024-02-13 | Areteia Therapeutics | Bain Capital Life Sciences investment in Series A - Areteia Therapeutics | 75 M USD |
| 2024-01-22 | Dianthus Therapeutics | Bain Capital Life Sciences investment in Post-IPO Equity - Dianthus Therapeutics | 230 M USD |
| 2024-01-08 | Solid Biosciences | Bain Capital Life Sciences investment in Post-IPO Equity - Solid Biosciences | 109 M USD |
Official Site Inspections
http://www.baincapitallifesciences.com Semrush global rank: 3.76 M Semrush visits lastest month: 3.18 K
- Host name: 104.18.29.132
- IP address: 104.18.29.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bain Capital Life Sciences"
Bain Capital Life Sciences - Crunchbase Company …
Bain Capital Life Sciences targeted $2 billion for its next life sciences fund. Additionally, Bain Capital Life Sciences invested in Freenome, which raised $254 million in new funding to accelerate its platform for early cancer detection, and …See details»
Bain Capital Life Sciences Raises Fourth Fund
Sep 10, 2024 Bain Capital Life Sciences (www.baincapitallifesciences.com) was founded in 2016 and builds on Bain Capital’s forty-year history of healthcare and life sciences investing across private equity, public equity, credit, venture …See details»
Bain Capital Life Sciences investment portfolio
Feb 12, 2025 www.baincapitallifesciences.com. Year Founded. 2016. Investor Status. Actively Seeking New Investments. Primary Investor Type. Corporate Venture Capital. Other Investor Types. Growth/Expansion. PE/Buyout. …See details»
Bain Capital
Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners for lasting impact.See details»
Bain Capital Life Sciences - Private Equity Investments & Executives
See Bain Capital Life Sciences's 56 investments, 13 executives, and complete investor profile. Bain Capital Life Sciences invests in biopharmaceutical, specialty pharmaceutical, medical …See details»
Bain Capital Life Sciences - SPEEDA Edge
Bain Capital Life Sciences specializes in buyouts, inflexion capital, growth capital, turnaround investments, and private equity. It invests in pharmaceutical, biotechnology, medical device, …See details»
Bain Capital Private Equity
Mar 6, 2025 Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in …See details»
About Bain Capital Life Sciences
Sep 30, 2024 Bain Capital Life Sciences was founded in 2016 and builds on Bain Capital’s forty-year history of healthcare and life sciences investing across private equity, public equity, …See details»
Investments - Bain Capital Life Sciences
Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.See details»
Bain Capital Life Sciences - Venture Capital Investor - Tracxn
6 days ago Bain Capital Life Sciences is a venture capital firm founded in 1984.It is primarily based out of Boston, United States. As of Apr 2025, Bain Capital Life Sciences is an active …See details»
Bain Capital Life Sciences collects about $3bn for fourth fund
Sep 10, 2024 Bain Capital Life Sciences collects about $3bn for fourth fund. The fund includes approximately $2.5 billion of outside commitments from existing and new investors while Bain …See details»
Bain Capital Life Sciences - CB Insights
Sep 17, 2024 Bain Capital Life Sciences is a global investment firm focused on driving medical innovation in the life sciences sector. Use the CB Insights Platform to explore Bain Capital Life …See details»
People - Bain Capital
Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners …See details»
Bain Capital Life Sciences
Bain Capital Life Sciences targets inflection points where capital and expertise can drive transformational growth. They focus on pharmaceuticals, biotechnology, medical devices, …See details»
Bain Capital raises $720 million for life sciences fund
May 23, 2017 Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our …See details»
Strategy - Bain Capital Life Sciences
Bain Capital Life Sciences seeks to build a diverse portfolio of high-impact, high-value-creating companies by adhering to our Guiding Principles in our rigorous, science-first diligence.See details»
Bain Capital Life Sciences secures $3 billion for fourth fund
Sep 12, 2024 Bain Capital Life Sciences has closed its fourth fund, securing approximately $3 billion, including $2.5 billion from investors and additional contributions from Bain partners, …See details»
Lincoln Financial and Bain Capital Announce Long-Term Strategic ...
1 day ago Lincoln, a trusted provider of retail life and annuity solutions and workplace benefits, and Bain Capital, a leading global investment firm, announced the formation of a strategic …See details»
Lincoln Financial and Bain Capital Announce Long-Term Strategic ...
1 day ago We look forward to working closely with the Lincoln team to further their organization in driving meaningful scale and profitable growth." The parties have signed a definitive …See details»
News - Bain Capital Life Sciences
Log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.comSee details»